特发性炎症性肌病中对氧磷酶-1(PON1)酶活性异常
该研究纳入184例特发性炎症性肌病(IIM)患者和112名健康对照,评估PON1酶活性及Q192R基因多态性。IIM患者PON1的芳基酯酶和內酯酶活性显著低于健康对照,且与疾病活动度、严重ILD及MDA5/抗合成酶抗体相关;PON1 QQ基因型患者疾病结局更好。
要点
- IIM患者PON1芳基酯酶和內酯酶活性显著低于健康对照。
- PON1活性降低与高疾病活动度、严重ILD及MDA5/抗合成酶抗体相关。
- PON1 QQ基因型患者较QR或RR基因型疾病结局更优。
核心结论
- IIM患者PON1芳基酯酶和內酯酶活性显著受损,且与疾病活动度和严重ILD呈负相关。
- PON1 QQ基因型与IIM患者更有利的疾病结局相关。
研究设计与样本
- 研究纳入184例IIM患者和112名健康对照,采用对氧磷酶、芳基酯酶和內酯酶试验评估PON1酶活性,并分析Q192R单核苷酸多态性(SNP)。
- 使用多变量回归模型检验PON1活性与IIM诊断及肌炎疾病结局的关联。
主要发现
- IIM患者PON1的芳基酯酶和內酯酶活性显著低于健康对照。
- 较高的肌炎疾病活动度、存在严重IIM相关间质性肺病(ILD)以及存在MDA5或抗合成酶抗体均与较低的PON1活性显著相关。
- PON1 Q192R多态性与IIM中对氧磷酶活性强相关,PON1 QQ基因型患者较QR或RR基因型患者疾病结局更好。
临床怎么用
- PON1活性及Q192R基因型可能有助于评估IIM患者疾病活动度及严重ILD风险,QQ基因型提示预后较好。
局限性
- 需大型前瞻性研究进一步评估PON1及其基因多态性在IIM和IIM-ILD发生发展中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Patients with idiopathic inflammatory myopathies (IIM) have severe vascular involvement, which contributes to disease morbidity and mortality. Paraoxonase-1 (PON1) is a high-density lipoprotein (HDL) associated protein that protects the vascular endothelium from oxidative injury and damage. The current work assessed the functional and genetic determinants of PON1 activity in IIM patients. METHODS: A total of 184 IIM patients and 112 healthy controls (HC) were included. PON1 enzyme activity was assessed by paraoxonase, arylesterase and lactonase assays, and the Q192R PON1 single nucleotide polymorphism (SNP) was analysed. Multivariate regression models examined associations of PON1 activity with IIM diagnosis and myositis disease outcomes. RESULTS: The arylesterase and lactonase activities of PON1 were significantly lower in IIM patients compared with HC. Higher myositis disease activity, the presence of severe IIM-associated interstitial lung disease (ILD), and the presence of MDA5 or anti-synthetase antibodies were significantly associated with lower PON1 activity. The PON1 Q192R polymorphism was strongly linked to the paraoxonase activity of PON1 in IIM, and patients with the PON1 QQ genotype had better IIM disease outcomes compared with patients with the QR or RR genotypes. CONCLUSIONS: The arylesterase and lactonase activities of PON1 are significantly impaired in IIM patients compared with HC, and inversely associate with IIM disease activity and the presence of severe ILD. The PON1 QQ genotype associates with more favourable disease outcomes in IIM patients. Large prospective studies are needed to further evaluate the role of PON1 and PON1 genetic polymorphisms in the development and propagation of IIM and IIM-ILD.
引用
- Bae SS, Shahbazian A, Wang J, et al. Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies. Rheumatology (Oxford). 2022. PMID: 34698804. doi:10.1093/rheumatology/keab795
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。